Investors Grab JNCE Even Cheaper Than Its Secondary Stock Offering

Looking back to 7 days ago, Jounce Therapeutics Inc (JNCE) priced a 5,000,000 share secondary stock offering at $11.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.